Five employees and one customer of PerkinElmer France teamed up to participate in a 24 h relay bicycle race near Tours (France) in support of cancer research. The September event benefited the ARC Foundation, a major French cancer research organization. Riding a combined 390 km (242 miles), the team won second place in the ?Companies Challenge? portion of the event. PerkinElmer France donated one euro for each kilometre ridden, with proceeds going to the ARC Foundation to help research into cures for cancer.
Left to right: Yvan Tacher (Service Engineer EH), Philippe Boniteau (LC specialist), David Rousseau (Service Engineer EH), Pierre Platon (Service Enginneer EH), Arnaud Ville (Service Engineer EH) and Michael Lozac’h (our customer from Francos Cie).
Five employees and one customer of PerkinElmer France teamed up to participate in a 24 h relay bicycle race near Tours (France) in support of cancer research. The September event benefited the ARC Foundation (http://www.arc-cancer.net), a major French cancer research organization. Riding a combined 390 km (242 miles), the team won second place in the “Companies Challenge” portion of the event. PerkinElmer France donated one euro for each kilometre ridden, with proceeds going to the ARC Foundation to help research into cures for cancer.
It was the second year in a row that a PerkinElmer team participated in the annual relay race - in 2012 it was held in Buthiers (France). The team this year consisted of Yvan Tacher (Service Engineer Environmental Health), Philippe Boniteau (LC specialist), David Rousseau (Service Engineer Environmental Health), Pierre Platon (Service Engineer Environmental Health), Arnaud Ville (Service Engineer Environmental Health), and Michael Lozac’h, a customer from Francos Cie.
Philippe Boniteau said: “It was easy to connect our fabulous team spirit to the CSR [Corporate Responsibility] programme from PerkinElmer.” He added: “It was an additional source of motivation to learn that management would join our efforts by donating one euro per kilometre for the ARC. Our only wish now is to be able to have more colleagues joining us in the future in order to perpetuate these kinds of initiatives and make them even more successful.”
PerkinElmer’s Corporate Social Responsibility programme encourages employees to make a positive difference in their communities, and each year an increasing number of employees from around the world partake in community involvement.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.